Related Articles
Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer
Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy
Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer
Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S‑1 adjuvant chemotherapy
Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1